Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (6): 30-37.doi: 10.6040/j.issn.1671-7554.0.2024.0261
• Preclinical Medicine • Previous Articles
WANG Xiao1, KONG Wenru1, CUI Weiliang2, WANG Shuqi1
CLC Number:
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [2] Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480. [3] Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut, 2017, 66(4): 683-691. [4] Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013[J]. J Natl Cancer Inst, 2017, 109(8): djw322. doi:10.1093/jnci/djw322. [5] Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010[J]. JAMA Surg, 2015, 150(1): 17-22. [6] Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2018, 68(4): 250-281. [7] Kasi PM, Shahjehan F, Cochuyt JJ, et al. Rising proportion of young individuals with rectal and colon cancer[J]. Clin Colorectal Cancer, 2019, 18(1): e87-e95. [8] Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2018, 29(Suppl 4): iv263. doi:10.1093/annonc/mdy161. [9] Vodenkova S, Buchler T, Cervena K, et al. 5-Fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future[J]. Pharmacol Ther, 2020, 206: 107447. doi:10.1016/j.pharmthera.2019.107447. [10] Veenstra CM, Krauss JC. Emerging systemic therapies for colorectal cancer[J]. Clin Colon Rectal Surg, 2018, 31(3): 179-191. [11] Blondy S, David V, Verdier M, et al. 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes[J]. Cancer Sci, 2020, 111(9): 3142-3154. [12] Heidelberger C, Chaudhuri NK, Danneberg P, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds[J]. Nature, 1957, 179(4561): 663-666. [13] Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20, 898 patients on 18 randomized trials[J]. J Clin Oncol, 2009, 27(6): 872-877. [14] Latchman J, Guastella A, Tofthagen C. 5-Fluorouracil toxicity and dihydropyrimidine dehydrogenase enzyme: implications for practice[J]. Clin J Oncol Nurs, 2014, 18(5): 581-585. [15] Zhang LL, Xing XL, Meng FL, et al. Oral fluoropyrimidine versus intravenous 5-fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta-analysis[J]. J Gastroenterol Hepatol, 2018, 33(1): 209-225. [16] Ahn DH, Wu C, Wei L, et al. The efficacy of adjuvant chemotherapy in patients with stage II/III resected rectal cancer treated with neoadjuvant chemoradiation therapy[J]. Am J Clin Oncol, 2017, 40(6): 531-534. [17] Lee GY, Lee JS, Son CG, et al. Combating drug resistance in colorectal cancer using herbal medicines[J]. Chin J Integr Med, 2021, 27(7): 551-560. [18] Li YQ, Cai J, Cheng JX, et al. Alstomairines D-G: new monoterpenoid indole alkaloids with cytotoxic activity from Alstonia mairei[J]. J Mol Struct, 2022, 1253: 132277. doi:10.1016/j.molstruc.2021.132277. [19] Yan TL, Han DX, Hu J, et al. Monoterpenoid indole alkaloids from Alstonia mairei and their cytotoxicity[J]. J Asian Nat Prod Res, 2017, 19(6): 550-556. [20] Cai XH, Zeng CX, Feng T, et al. Monoterpenoid indole alkaloids from Alstonia mairei[J]. Helv Chim Acta, 2010, 93(10): 2037-2044. [21] Sobrero A, Aschele C, Guglielmi A, et al. Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications[J]. J Chemother, 1990, 2(Suppl 1): 12-16. [22] Johnston PG, Kaye S. Capecitabine: a novel agent for the treatment of solid tumors[J]. Anticancer Drugs, 2001, 12(8): 639-646. [23] Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies[J]. Nat Rev Cancer, 2003, 3(5): 330-338. [24] Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil[J]. Clin Pharmacokinet, 1989, 16(4): 215-237. |
[1] | WEI Yanruoxue, LI Ziqi, LIU Chuncheng, LIU Xiaohan, ZHAO Ran, LIU Yukun. Intratumor heterogeneity of SP1 expression in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 89-94. |
[2] | LIU Chuncheng, LIU Xiaohan, WEI Yanruoxue, LI Ziqi, LIU Yukun, ZHAO Ran. Subcellular localization pattern of bromodomain containing 9 in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 24-30. |
[3] | JING Kai, XU Zhiwei, LI Leping. Exploring colorectal cancer related genes and their functions based on GEO [J]. Journal of Shandong University (Health Sciences), 2024, 62(1): 21-30. |
[4] | DONG Yaqi, WANG Xinhui, ZHAO Yinghui, WANG Chuanxin. Clinical value of serum exosomal LINC02163 as a marker for distant metastasis of colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(9): 19-28. |
[5] | SUN Fuyun, WANG Weipeng, ZHANG Huihui, GENG Yan, AN Xiaoxia, LI Shuangshuang, ZHANG Binbin. Correlation among personality traits and depression, anxiety symptoms in patients after colorectal cancer resection [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 91-96. |
[6] | DU Tiantian, LI Juan, ZHAO Yinghui, DUAN Weili, WANG Jing, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression profiles of long non-coding RNA LINC02474 and effects on cell proliferation in colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 59-69. |
[7] | LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38-46. |
[8] | WANG Tianxiao, LI Jing, LI Hailin. Evaluation of an e-questionnaire in the early screening of colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 90-94. |
[9] | HONG Jiageng, NIE Yangyang, SU Guoqiang. Effects of propofol on proliferation, migration and expressions of Wnt1 and β-catenin in colon cancer cells [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 53-58. |
[10] | LI Leping, CUI Huaiping, SHANG Liang. Application of enhanced recovery after surgery in gastrointestinal surgery [J]. Journal of Shandong University (Health Sciences), 2019, 57(9): 5-11. |
[11] | WU Chengwei, SUN Boshi, ZHOU Junde, JIANG Tianming, CHI Qiang. Association between preoperative oral polysaccharide solution and insulin resistance in patients with colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(9): 48-53. |
[12] | 8.GUO Yan, ZHANG Zheying, WANG Yunxi, WEI Xiaojuan. Expression and clinical significance of homo sapiens longevity assurance homologue 2 of yeast LAG1 in colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(7): 67-71. |
[13] | WAN Xiuxia, SUN Xiuping, TONG Jingjie. Anticancer effect of chrysophanol on colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(5): 74-79. |
[14] | GENG Xu, ZHANG Lu, LI Ming, LU Zhiming. Application value of combined detection of tumor-associated autoantibodies in the diagnosis of colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2019, 57(4): 65-71. |
[15] | MA Ranran, HAN Chen, WANG Zhaoxia, WANG Zhaopeng, GAO Yuxin, ZHOU Shuping, ZHANG Yueying, LI Xiaobing, LIU Hengyao, WANG Hengxiao. Total saponins of Panax ginseng promoting the anticancer activity of 5-Fluorouracil by mediating NK cell activity [J]. Journal of Shandong University (Health Sciences), 2018, 56(4): 43-50. |
|